News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
275,234 Results
Type
Article (14797)
Company Profile (283)
Press Release (260154)
Section
Business (82183)
Career Advice (159)
Deals (13805)
Drug Delivery (34)
Drug Development (53652)
Employer Resources (33)
FDA (6197)
Job Trends (5328)
News (151407)
Policy (10973)
Tag
Academia (918)
Alliances (22129)
Alzheimer's disease (792)
Antibody-drug conjugate (ADC) (69)
Approvals (6182)
Artificial intelligence (86)
Bankruptcy (104)
Best Places to Work (4712)
Biotechnology (233)
Breast cancer (121)
Cancer (1074)
Cardiovascular disease (85)
Career advice (138)
CAR-T (86)
Cell therapy (255)
Clinical research (43236)
Collaboration (393)
Compensation (156)
COVID-19 (1028)
C-suite (102)
Cystic fibrosis (77)
Data (1101)
Diabetes (98)
Diagnostics (1240)
Earnings (30494)
Events (49465)
Executive appointments (323)
FDA (6672)
Funding (373)
Gene editing (71)
Gene therapy (190)
GLP-1 (339)
Government (1176)
Healthcare (6841)
Infectious disease (1069)
Inflammatory bowel disease (100)
IPO (7571)
Job creations (913)
Job search strategy (133)
Layoffs (198)
Legal (1466)
Lung cancer (157)
Lymphoma (73)
Manufacturing (95)
Medical device (2606)
Medtech (2607)
Mergers & acquisitions (6430)
Metabolic disorders (298)
Neuroscience (1094)
NextGen: Class of 2025 (2149)
Non-profit (897)
Northern California (1244)
Obesity (160)
Opinion (96)
Parkinson's disease (86)
Patents (72)
People (25856)
Phase I (15025)
Phase II (20162)
Phase III (12927)
Pipeline (465)
Postmarket research (888)
Preclinical (6132)
Radiopharmaceuticals (208)
Rare diseases (243)
Real estate (1481)
Regulatory (9180)
Research institute (964)
Series A (73)
Southern California (1121)
Startups (2000)
United States (9977)
Vaccines (180)
Weight loss (93)
Date
Today (54)
Last 7 days (358)
Last 30 days (1414)
Last 365 days (21097)
2025 (1370)
2024 (21255)
2023 (23225)
2022 (27886)
2021 (28886)
2020 (24509)
2019 (17051)
2018 (12430)
2017 (14721)
2016 (12645)
2015 (15324)
2014 (11032)
2013 (7936)
2012 (7892)
2011 (7947)
2010 (7714)
Location
Africa (152)
Asia (17824)
Australia (2961)
California (2842)
Canada (899)
China (259)
Colorado (106)
Connecticut (118)
Europe (39191)
Florida (335)
Georgia (82)
Illinois (181)
Indiana (73)
Maryland (381)
Massachusetts (2291)
Minnesota (114)
New Jersey (723)
New York (781)
North Carolina (451)
Northern California (1244)
Ohio (90)
Pennsylvania (550)
South America (219)
Southern California (1121)
Texas (330)
Washington State (272)
275,234 Results for "jupiter orphan therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
January 14, 2025
·
6 min read
Press Releases
Actuate Therapeutics Receives EMA Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer
January 7, 2025
·
6 min read
Press Releases
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
December 4, 2024
·
3 min read
Press Releases
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
December 3, 2024
·
4 min read
Press Releases
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS
November 19, 2024
·
3 min read
Press Releases
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
November 20, 2024
·
6 min read
Press Releases
YolTech Therapeutics Granted FDA Orphan Drug and Rare Pediatric Disease Designations for YOLT-203 to Treat Primary Hyperoxaluria Type 1
December 29, 2024
·
3 min read
Biotech Bay
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT1100 for the Treatment of Primary Ciliary Dyskinesia
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for RCT1100 for the treatment of primary ciliary dyskinesia (PCD).
June 27, 2024
·
4 min read
Press Releases
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
November 11, 2024
·
4 min read
Lone Star Bio
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
Nanoscope Therapeutics Inc. today announced that Sulagna Bhattacharya , Chief Executive Officer and Samarendra Mohanty, PhD, President and Chief Scientific Officer will present and participate in a panel discussion at the World Orphan Drug Congress 2024, taking place from April 23-25, 2024 in Boston, Massachusetts.
April 17, 2024
·
2 min read
1 of 27,524
Next
